Dr. Manish Kohli, MD

Dr. Kohli practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Kohli's NPI, 1407804040, was assigned on May 5, 2006. Dr. Kohli graduated from Maulana Azad Medical College in 1990. Dr. Kohli's Minnesota license number on file is 50887.

Dr. Kohli's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Kohli's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Kohli is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. Kohli to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kohli practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Kohli's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kohli is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Kohli's licenses on file in 6 states: Minnesota, New York, Utah, Florida, Arkansas and Illinois.

Dmand AI lists prostate cancer among the conditions Dr. Kohli treats.

CMS data shows 280 Medicare services from Dr. Kohli across 3 procedure codes in 2024, for 67 Medicare patients. Medicare paid $14,774 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 67 Medicare patients who saw Dr. Kohli in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have cancer, and 73% have high blood pressure. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kohli's median patient age at 76, with 3% women.

In 2024, Dr. Kohli wrote 347 Medicare Part D claims for 40 patients. 84% of them were for generic drugs. CMS names the drug for 295 of them, across 5 drugs with 11 or more claims each, at $765,186 in total drug cost. In 2023, CMS named 207 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Kohli for performance year 2024, reported as part of a group. Dr. Kohli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 207 papers to Dr. Kohli, published from 2010 to 2025. 2021 was the busiest year, with 18. The most frequent topics are Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant and Prostate-Specific Antigen. Dr. Kohli has published most often in Mayo Clin Proc. Dr. Kohli's most frequent co-authors are Winston Tan, MD, Brian A. Costello, MD and Benjamin Louis Maughan, MD.

Dmand AI links Dr. Kohli to 7 clinical trials, 3 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Urethral Neoplasms. Mayo Clinic sponsors the most, 2.

CMS Open Payments shows 36 general payments to Dr. Kohli from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. Advanced Accelerator Applications paid the most, $5,330.

Dmand AI lists 7 awards for Dr. Kohli, most recently "Movember" Challenge Award Honoree in 2015.

Dr. Kohli graduated from Maulana Azad Medical College in 1990. Dr. Kohli is a member of American Association of Cancer Research and ASCO.

Dr. Kohli is in network with 18 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.